Atlas Trials

Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study

Clinical trial NCT03167541 · COMPLETED

Trial details

NCT number
NCT03167541
Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2016-10-12
Primary completion
2016-12-02
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.